← Back to headlines
Medline shares fall after Q2 beat but cut to EBITDA outlook
Medline's shares fell despite reporting a beat in its second-quarter earnings. The decline followed a cut to the company's EBITDA outlook.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
